Humana Inc.
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Humana Inc. ("Humana" or the "Company") (NYSE: HUM) and reminds investors of the August 2, 2024 deadline to seek the role of lead plaintiff in a federal ...
James M. Wilson, Jr., Robert W. Killorin at New York office
Enphase Energy, Inc.
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Enphase Energy, Inc. ("Enphase" or the "Company") (NASDAQ: ENPH) and reminds investors of the July 29, 2024 deadline to seek the role of lead plaintiff ...
James M. Wilson, Jr., Robert W. Killorin at New York office
Fastly, Inc.
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Fastly, Inc. ("Fastly" or the "Company") (NYSE: FSLY) and reminds investors of the July 23, 2024 deadline to seek the role of lead plaintiff in a federal ...
James M. Wilson, Jr., Robert W. Killorin at New York office
Direct Digital Holdings, Inc.
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Direct Digital Holdings, Inc. ("Direct Digital" or the "Company") (NASDAQ: DRCT) and reminds investors of the July 22, 2024 deadline to seek the role ...
James M. Wilson, Jr., Robert W. Killorin at New York office
Biogen Inc.
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Biogen Inc. ("Biogen" or the "Company") (NASDAQ: BIIB) and reminds investors of the July 22, 2024 deadline to seek the role of lead plaintiff in a ...
James M. Wilson, Jr., Robert W. Killorin at New York office
Cambium Networks Corporation
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Cambium Networks Corporation ("Cambium" or the "Company") (NASDAQ: CMBM) and reminds investors of the July 22, 2024 deadline to seek the role of lead ...
James M. Wilson, Jr., Robert W. Killorin at New York office
Rivian Automotive, Inc.
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Rivian Automotive, Inc. ("Rivian" or the "Company") (NASDAQ: RIVN) and reminds investors of the July 30, 2024 deadline to seek the role of lead plaintiff ...
James M. Wilson, Jr., Robert W. Killorin at New York office
World Acceptance Corporation
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In World Acceptance To Contact Him Directly To Discuss Their Options If you suffered significant losses in World Acceptance stock or options and would ...
James M. Wilson, Jr., Robert W. Killorin at New York office
Temenos AG
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Temenos To Contact Him Directly To Discuss Their Options If you suffered significant losses in Temenos stock or options and would like to discuss ...
James M. Wilson, Jr., Robert W. Killorin at New York office
Lordstown Motors Corp.
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Lordstown To Contact Him Directly To Discuss Their Options Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating ...
James M. Wilson, Jr., Robert W. Killorin at New York office
Argo Blockchain plc
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Argo To Contact Him Directly To Discuss Their Options Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential ...
James M. Wilson, Jr., Robert W. Killorin at New York office
NewAge, Inc.
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In NewAge To Contact Him Directly To Discuss Their Options Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential ...
James M. Wilson, Jr., Robert W. Killorin at New York office
Revance Therapeutics, Inc.
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Revance Therapeutics To Contact Him Directly To Discuss Their Options Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating ...
James M. Wilson, Jr., Robert W. Killorin at New York office
Peloton Interactive Inc. (PTON)
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Peloton To Contact Him Directly To Discuss Their Options Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential ...
Robert W. Killorin, James M. Wilson, Jr. at New York office
Teva Pharmaceutical Industries Limited (TEVA)
TEVA DEADLINE ALERT Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Teva To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 investing in Teva stock or options ...
James M. Wilson, Jr., Robert W. Killorin at New York office
Amneal Pharmaceuticals, Inc. (AMRX)
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Amneal Pharmaceuticals, Inc. To Contact The Firm Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Amneal ...
James M. Wilson, Jr., Robert W. Killorin at New York office